Zynex (ZYXI) Competitors $8.26 +0.15 (+1.85%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZYXI vs. AXGN, PLSE, BVS, EYE, CBLL, FNA, LQDA, AVNS, EMBC, and BFLYShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include AxoGen (AXGN), Pulse Biosciences (PLSE), Bioventus (BVS), National Vision (EYE), CeriBell (CBLL), Paragon 28 (FNA), Liquidia (LQDA), Avanos Medical (AVNS), Embecta (EMBC), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry. Zynex vs. AxoGen Pulse Biosciences Bioventus National Vision CeriBell Paragon 28 Liquidia Avanos Medical Embecta Butterfly Network AxoGen (NASDAQ:AXGN) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations. Is AXGN or ZYXI more profitable? Zynex has a net margin of 2.49% compared to AxoGen's net margin of -7.91%. Zynex's return on equity of 13.05% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-7.91% -14.91% -7.49% Zynex 2.49%13.05%3.78% Do insiders & institutionals have more ownership in AXGN or ZYXI? 80.3% of AxoGen shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 7.0% of AxoGen shares are held by insiders. Comparatively, 52.1% of Zynex shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better earnings & valuation, AXGN or ZYXI? Zynex has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$159.01M3.69-$21.72M-$0.32-41.69Zynex$184.32M1.43$9.73M$0.1555.07 Does the media refer more to AXGN or ZYXI? In the previous week, AxoGen had 2 more articles in the media than Zynex. MarketBeat recorded 2 mentions for AxoGen and 0 mentions for Zynex. AxoGen's average media sentiment score of 0.95 beat Zynex's score of -0.55 indicating that AxoGen is being referred to more favorably in the media. Company Overall Sentiment AxoGen Positive Zynex Negative Does the MarketBeat Community prefer AXGN or ZYXI? AxoGen received 425 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 72.71% of users gave AxoGen an outperform vote while only 57.14% of users gave Zynex an outperform vote. CompanyUnderperformOutperformAxoGenOutperform Votes45372.71% Underperform Votes17027.29% ZynexOutperform Votes2857.14% Underperform Votes2142.86% Do analysts recommend AXGN or ZYXI? AxoGen currently has a consensus target price of $15.00, indicating a potential upside of 12.44%. Zynex has a consensus target price of $14.00, indicating a potential upside of 69.49%. Given Zynex's higher probable upside, analysts clearly believe Zynex is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Zynex 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, AXGN or ZYXI? AxoGen has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. SummaryZynex beats AxoGen on 9 of the 17 factors compared between the two stocks. Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$263.08M$3.52B$5.21B$8.85BDividend YieldN/A1.72%5.53%4.08%P/E Ratio55.0713.3973.5814.36Price / Sales1.4396.201,248.4887.29Price / Cash19.7146.0640.8336.89Price / Book7.384.087.196.54Net Income$9.73M$89.83M$119.47M$226.15M7 Day Performance5.90%0.59%2.11%3.76%1 Month Performance-1.20%6.41%-2.45%4.63%1 Year Performance-9.03%21.31%34.51%29.20% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex3.7398 of 5 stars$8.26+1.8%$14.00+69.5%-9.0%$263.08M$184.32M55.071,100AXGNAxoGen2.7093 of 5 stars$13.10+1.6%$15.00+14.5%+126.1%$576.53M$159.01M-40.94426PLSEPulse Biosciences1.6172 of 5 stars$16.24+0.6%N/A+164.3%$999.07M$700,000.000.00140BVSBioventus2.7235 of 5 stars$11.50+0.8%$13.00+13.0%+206.5%$933.23M$512.34M29.721,200Positive NewsEYENational Vision3.1337 of 5 stars$11.51+1.5%$14.00+21.7%-40.2%$906.02M$2.13B-56.7013,998Positive NewsCBLLCeriBellN/A$25.24+0.7%$31.20+23.6%N/A$903.92MN/A0.00N/AQuiet Period ExpirationFNAParagon 282.4321 of 5 stars$10.43+0.8%$15.60+49.6%-0.9%$873.20M$216.39M-13.99343,000Insider TradeLQDALiquidia3.814 of 5 stars$10.15+0.3%$24.00+136.5%+58.5%$859.10M$17.49M-6.2150Positive NewsAVNSAvanos Medical3.8079 of 5 stars$18.02+0.8%N/A-12.9%$828.20M$673.30M54.003,771Analyst RevisionPositive NewsEMBCEmbecta0.9062 of 5 stars$13.95+2.5%$12.00-14.0%-21.6%$804.66M$1.12B11.542,200Upcoming EarningsBFLYButterfly Network0.7714 of 5 stars$3.30-0.6%$3.00-9.0%+217.6%$702.10M$65.90M-7.67460 Related Companies and Tools Related Companies AxoGen Alternatives Pulse Biosciences Alternatives Bioventus Alternatives National Vision Alternatives CeriBell Alternatives Paragon 28 Alternatives Liquidia Alternatives Avanos Medical Alternatives Embecta Alternatives Butterfly Network Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZYXI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
